Page 215 - ஒன்றுபட்டது மாநிலங்களில் மாவட்டம் நீதிமன்றம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

    Toll free (844) 887-9500 Athira is a late-stage clinical biopharmaceutical company that focuses on developing small molecules to restore neuronal health and stop neurodegeneration. The complaints allege that in the Registration Statement and/or throughout the Class Period the defendants made materially false and misleading statements and omitted to state that: (1) Athira’s president and Chief Executive Officer, Dr. Leen Kawas, had published research papers containing improperly altered images while she was a graduate student; (2) this purported research was foundational to Athira’s efforts to develop treatments for Alzheimer’s because it laid the biological groundwork that Athira was using in its approach to treating Alzheimer’s; (3) as a result, Athira’s intellectual property and product development for the treatment of Alzheimer’s was based on invalid research; and (4) as a result of the foregoing, the defendants’ positive statements about Athira’s busines

United statesAdrienne bellJames maro jrJames maroAthira pharma incUnited states district courtKessler topaz meltzerWestern districtAthira pharmaPlaintiff deadlineRegistration statementClass periodChief executive officerLeen kawasTopaz meltzerஒன்றுபட்டது மாநிலங்களில்